SCHEMBL380896

SCHEMBL380896

[c]1occc1SCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.41
HSD17B10 Q99714 2/20 0.41
RAB9A P51151 6/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
ALDH1A1 P00352 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
EGFR P00533 1/20 0.38
NPC1 O15118 3/20 0.37
MAOA P21397 2/20 0.37
MAOB P27338 2/20 0.37
TP53 P04637 1/20 0.36
ABL1 P00519 1/20 0.36
RIN1 Q13671 1/20 0.36
HPGD P15428 2/20 0.36
ALOX15 P16050 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1128286 0.69 HPGD (0.35) HSD17B10SMN1; SMN2ALDH1A1MAOAMAOB
SCHEMBL2351201 0.69 CALM1 (0.46) RAB9ASMN1; SMN2ALDH1A1NPC1TP53
SCHEMBL4302 0.68 POLB (0.44) POLBHSD17B10RAB9ASMN1; SMN2ALDH1A1
SCHEMBL8381428 0.68 MAOA (0.40) HSD17B10SMN1; SMN2ALDH1A1MAOAMAOB
SCHEMBL367099 0.67 POLB (0.56) POLBHSD17B10RAB9ASMN1; SMN2L3MBTL1
SCHEMBL997130 0.65 POLB (0.41) POLBHSD17B10RAB9ASMN1; SMN2ALDH1A1
SCHEMBL14483860 0.65 CYP2C19 (0.50) POLBHSD17B10RAB9ASMN1; SMN2ALDH1A1
SCHEMBL332623 0.65 MAOA (0.63) POLBHSD17B10RAB9ASMN1; SMN2ALDH1A1
SCHEMBL28647335 0.64 POLB (0.44) POLBHSD17B10RAB9ASMN1; SMN2ALDH1A1
SCHEMBL6607295 0.64 POLB (0.44) POLBHSD17B10RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 455 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015086793-A1 POLYMER SUPPORTED PHOSPHORIC ACIDS AND USE THEREOF AS CATALYSTS IN THE PREPARATION OF 3-INDOLYLMETHANAMINES FUNDACIÓ INSTITUT CATALÀ D'INVESTIGACIÓ QUÍMICA (ICIQ) (ES) 2015-06-18 WO claimed
EP-2883879-A1 Polymer supported phosphoric acids and use thereof as catalysts in the preparation of 3-indolylmethanamines Fundació Institut Català d'Investigació Química (ES) 2015-06-17 EP claimed
US-20140221631-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2014-08-07 US claimed
US-8722917-B2 Boron-containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2014-05-13 US claimed
US-20120289686-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2012-11-15 US claimed
EP-2066789-A2 CRYSTAL STRUCTURE OF A TRNA SYNTHETASE Anacor Pharmaceuticals, Inc. (US) 2009-06-10 EP claimed
EP-1976536-A2 BORON-CONTAINING SMALL MOLECULES Anacor Pharmaceuticals, Inc. (US) 2008-10-08 EP claimed
WO-2008070257-A9 CRYSTAL STRUCTURE OF A TRNA SYNTHETASE ANACOR PHARMACEUTICALS INC (US) 2008-09-04 WO claimed
WO-2008070257-A2 CRYSTAL STRUCTURE OF A TRNA SYNTHETASE ANACOR PHARMACEUTICALS, INC. (US) 2008-06-12 WO claimed
WO-2007078340-A2 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2007-07-12 WO claimed
US-20070155699-A1 Boron-containing small molecules ANACOR PHARMACEUTICALS (US) 2007-07-05 US claimed
EP-1451147-A4 AMINO ACID DERIVATIVES PHARMACORE INC (US) 2007-06-06 EP claimed
US-6809207-B2 REACTING AMMONIUM FORMATE, ALDEHYDE AND ALKYL ISOCYANATE PHARMACORE, INC. 2004-10-26 US claimed
EP-1451147-A1 AMINO ACID DERIVATIVES PharmaCore, Inc, (US) 2004-09-01 EP claimed
US-20030064976-A1 Reacting ammonium formate, aldehyde and alkyl isocyanate PHARMACORE, INC. 2003-04-03 US claimed
WO-2003010130-A1 AMINO ACID DERIVATIVES PHARMACORE, INC. (US) 2003-02-06 WO claimed
EP-3556758-B1 1,2-DIHYDRO-1,6-NAPHTHYRIDIN-2-ONE DERIVATIVES AS CDK4/6 INHIBITORS CSTONE PHARMACEUTICALS SUZHOU CO LTD (CN) 2024-07-17 EP disclosed
EP-3712150-B1 MACROCYCLIC COMPOUND SERVING AS WEE1 INHIBITOR AND APPLICATIONS THEREOF WUXI BIOCITY BIOPHARMACEUTICS CO LTD (CN) 2024-06-12 EP disclosed
US-4970224-A INSECTICIDES ROHM AND HAAS COMPANY (US) 1990-11-13 US disclosed
EP-0337815-A1 1-dimethylcarbamoyl-3-substituted-5-substituted-1H-1,2,4-triazoles SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1989-10-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221631-A1 BORON-CONTAINING SMALL MOLECULES ETF1, POLR1C, DPM1 POLB 826/4885HSD17B10 2105/4885RAB9A 2224/4885
US-20030064976-A1 Reacting ammonium formate, aldehyde and alkyl isocyanate ALDH7A1, IL4I1, ABAT POLB 2594/4885HSD17B10 956/4885RAB9A 3374/4885
US-20120289686-A1 BORON-CONTAINING SMALL MOLECULES ETF1, POLR1C, DPM1 POLB 826/4885HSD17B10 2105/4885RAB9A 2224/4885
US-20070155699-A1 Boron-containing small molecules ETF1, POLR1C, DPM1 POLB 826/4885HSD17B10 2105/4885RAB9A 2224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.